{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:20:36Z","timestamp":1793967636709,"version":"4.8.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:00:00Z","timestamp":1763164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2022NW44H5 CUP: H53D23006210006"],"award-info":[{"award-number":["2022NW44H5 CUP: H53D23006210006"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["ECS00000041 - VITALITY - CUP H33C22000430006"],"award-info":[{"award-number":["ECS00000041 - VITALITY - CUP H33C22000430006"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"AIRC Foundation for Cancer Research","doi-asserted-by":"publisher","award":["IG 28733"],"award-info":[{"award-number":["IG 28733"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.phrs.2025.108037","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T16:47:01Z","timestamp":1763657221000},"page":"108037","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Pyrazolone-based ERO1 inhibitors in ERO1-driven triple-negative breast cancer and SEPN1-related myopathy: Structure\u2013activity relationship and therapeutic potential"],"prefix":"10.1016","volume":"222","author":[{"given":"Michele","family":"Retini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Cherubini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Marrazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ersilia","family":"Varone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Germani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia Maria","family":"Renna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Recchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Guidarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Fumagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Grasselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Mari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Piersanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Bottegoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Tonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Gobbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Ram","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaehyung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orazio","family":"Cantoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7786-7698","authenticated-orcid":false,"given":"Ester","family":"Zito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2025.108037_bib1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1097-2765(00)80198-7","article-title":"Ero1p oxidizes protein disulfide isomerase in a pathway for disulfide bond formation in the endoplasmic reticulum","volume":"4","author":"Frand","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2025.108037_bib2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.freeradbiomed.2015.01.011","article-title":"ERO1: A protein disulfide oxidase and H2O2 producer","volume":"83","author":"Zito","year":"2015","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.phrs.2025.108037_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111899","article-title":"The endoplasmic reticulum kinase PERK interacts with the oxidoreductase ERO1 to metabolically adapt mitochondria","volume":"42","author":"Bassot","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2025.108037_bib4","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1161\/CIRCRESAHA.121.320531","article-title":"Ero1alpha-dependent ERp44 dissociation from RyR2 contributes to cardiac arrhythmia","volume":"130","author":"Hamilton","year":"2022","journal-title":"Circ. Res"},{"key":"10.1016\/j.phrs.2025.108037_bib5","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1089\/ars.2011.4004","article-title":"Ero1alpha regulates Ca(2+) fluxes at the endoplasmic reticulum-mitochondria interface (MAM)","volume":"16","author":"Anelli","year":"2012","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.phrs.2025.108037_bib6","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1083\/jcb.200904060","article-title":"Role of ERO1-alpha-mediated stimulation of inositol 1,4,5-triphosphate receptor activity in endoplasmic reticulum stress-induced apoptosis","volume":"186","author":"Li","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.phrs.2025.108037_bib7","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1126\/science.1209038","article-title":"The unfolded protein response: from stress pathway to homeostatic regulation","volume":"334","author":"Walter","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.phrs.2025.108037_bib8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41573-021-00320-3","article-title":"Pharmacological targeting of endoplasmic reticulum stress in disease","volume":"21","author":"Marciniak","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2025.108037_bib9","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.molcel.2004.08.025","article-title":"Degradation of misfolded proteins prevents ER-derived oxidative stress and cell death","volume":"15","author":"Haynes","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2025.108037_bib10","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S1097-2765(03)00105-9","article-title":"An integrated stress response regulates amino acid metabolism and resistance to oxidative stress","volume":"11","author":"Harding","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2025.108037_bib11","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1101\/gad.1250704","article-title":"CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum","volume":"18","author":"Marciniak","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.phrs.2025.108037_bib12","article-title":"Fingerprint of the oxido-reductase ERO1: a protein disulfide bond producer and supporter of cancer","volume":"1879","author":"Zito","year":"2023","journal-title":"Biochim Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.phrs.2025.108037_bib13","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1111\/bph.15927","article-title":"Endoplasmic reticulum oxidoreductin 1-alpha deficiency and activation of protein translation synergistically impair breast tumour resilience","volume":"179","author":"Varone","year":"2022","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.phrs.2025.108037_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102455","article-title":"ERO1 alpha deficiency impairs angiogenesis by increasing N-glycosylation of a proangiogenic VEGFA","volume":"56","author":"Varone","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.phrs.2025.108037_bib15","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/s41388-021-01659-y","article-title":"The ER stress response mediator ERO1 triggers cancer metastasis by favoring the angiogenic switch in hypoxic conditions","volume":"40","author":"Varone","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2025.108037_bib16","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/sj.onc.1208325","article-title":"Ero1-L alpha plays a key role in a HIF-1-mediated pathway to improve disulfide bond formation and VEGF secretion under hypoxia: implication for cancer","volume":"24","author":"May","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2025.108037_bib17","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013162","article-title":"The NFIB-ERO1A axis promotes breast cancer metastatic colonization of disseminated tumour cells","author":"Zilli","year":"2021","journal-title":"EMBO Mol. Med"},{"key":"10.1016\/j.phrs.2025.108037_bib18","doi-asserted-by":"crossref","first-page":"8400","DOI":"10.7150\/thno.45124","article-title":"Endoplasmic Reticulum stress-dependent expression of ERO1L promotes aerobic glycolysis in Pancreatic Cancer","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.phrs.2025.108037_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13046-024-02990-4","article-title":"Biological mechanisms and clinical significance of endoplasmic reticulum oxidoreductase 1 alpha (ERO1alpha) in human cancer","volume":"43","author":"Chen","year":"2024","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.phrs.2025.108037_bib20","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ebiom.2019.02.041","article-title":"Targeting the functional interplay between endoplasmic reticulum oxidoreductin-1alpha and protein disulfide isomerase suppresses the progression of cervical cancer","volume":"41","author":"Zhang","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.phrs.2025.108037_bib21","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.21037\/tau-20-1025","article-title":"Endoplasmic reticulum oxidoreductase 1 alpha modulates prostate cancer hallmarks","volume":"10","author":"Cornelius","year":"2021","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.phrs.2025.108037_bib22","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/bjc.2016.105","article-title":"Cancer-associated oxidoreductase ERO1-alpha drives the production of VEGF via oxidative protein folding and regulating the mRNA level","volume":"114","author":"Tanaka","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phrs.2025.108037_bib23","article-title":"Ablation of ERO1A induces lethal endoplasmic reticulum stress responses and immunogenic cell death to activate anti-tumor immunity","author":"Liu","year":"2023","journal-title":"Cell Rep. Med"},{"key":"10.1016\/j.phrs.2025.108037_bib24","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.trecan.2022.06.006","article-title":"Decoding endoplasmic reticulum stress signals in cancer cells and antitumor immunity","volume":"8","author":"Salvagno","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.phrs.2025.108037_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-25198-y","article-title":"Loss-of-rescue of Ryr1(I4895T)-related pathology by the genetic inhibition of the ER stress response mediator CHOP","volume":"12","author":"Germani","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2025.108037_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/cells10051116","article-title":"Calcium and redox liaison: a key role of selenoprotein N in skeletal muscle","volume":"10","author":"Zito","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2025.108037_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2024.101439","article-title":"SEPN1-related myopathy depends on the oxidoreductase ERO1A and is druggable with the chemical chaperone TUDCA","author":"Germani","year":"2024","journal-title":"Cell Rep. Med"},{"key":"10.1016\/j.phrs.2025.108037_bib28","doi-asserted-by":"crossref","first-page":"20993","DOI":"10.1074\/jbc.M110.126599","article-title":"A small molecule inhibitor of endoplasmic reticulum oxidation 1 (ERO1) with selectively reversible thiol reactivity","volume":"285","author":"Blais","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2025.108037_bib29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41419-025-07426-1","article-title":"Small molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironment","volume":"16","author":"Varone","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2025.108037_bib30","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1161\/CIRCRESAHA.122.322473","article-title":"A Critical Role for ERO1alpha in arterial thrombosis and ischemic stroke","volume":"132","author":"Jha","year":"2023","journal-title":"Circ. Res"},{"key":"10.1016\/j.phrs.2025.108037_bib31","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.1016\/j.ymthe.2025.07.033","article-title":"Selective inhibition of ERO1alpha with M6766, a novel small-molecule inhibitor, prevents arterial thrombosis and ischemic stroke in mice","volume":"33","author":"Wang","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.phrs.2025.108037_bib32","doi-asserted-by":"crossref","first-page":"D1180","DOI":"10.1093\/nar\/gkad1004","article-title":"The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods","volume":"52","author":"Zdrazil","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.phrs.2025.108037_bib33","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1083\/jcb.200911086","article-title":"ERO1-beta, a pancreas-specific disulfide oxidase, promotes insulin biogenesis and glucose homeostasis","volume":"188","author":"Zito","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.phrs.2025.108037_bib34","doi-asserted-by":"crossref","first-page":"9627","DOI":"10.1016\/S0021-9258(19)83562-7","article-title":"Thioredoxin catalyzes the reduction of insulin disulfides by dithiothreitol and dihydrolipoamide","volume":"254","author":"Holmgren","year":"1979","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2025.108037_bib35","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","article-title":"Regulation and Function of the PD-L1 Checkpoint","volume":"48","author":"Sun","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2025.108037_bib36","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0006-3495(99)77214-0","article-title":"Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives","volume":"76","author":"Scaduto","year":"1999","journal-title":"Biophys. J."},{"key":"10.1016\/j.phrs.2025.108037_bib37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2144\/000113610","article-title":"Mitochondrial membrane potential probes and the proton gradient: a practical usage guide","volume":"50","author":"Perry","year":"2011","journal-title":"Biotechniques"},{"key":"10.1016\/j.phrs.2025.108037_bib38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41418-020-0587-z","article-title":"Defective endoplasmic reticulum-mitochondria contacts and bioenergetics in SEPN1-related myopathy","volume":"28","author":"Filipe","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.phrs.2025.108037_bib39","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1089\/ars.2021.0018","article-title":"ERO1-PDI Redox Signaling in Health and Disease","volume":"35","author":"Jha","year":"2021","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.phrs.2025.108037_bib40","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1089\/ars.2012.4966","article-title":"PRDX4, an endoplasmic reticulum-localized peroxiredoxin at the crossroads between enzymatic oxidative protein folding and nonenzymatic protein oxidation","volume":"18","author":"Zito","year":"2013","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.phrs.2025.108037_bib41","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.molcel.2010.11.010","article-title":"Oxidative protein folding by an endoplasmic reticulum-localized peroxiredoxin","volume":"40","author":"Zito","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2025.108037_bib42","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1038\/emboj.2010.273","article-title":"Recycling of peroxiredoxin IV provides a novel pathway for disulphide formation in the endoplasmic reticulum","volume":"29","author":"Tavender","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.phrs.2025.108037_bib43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.molcel.2012.08.010","article-title":"Endoplasmic Reticulum Thiol Oxidase Deficiency Leads to Ascorbic Acid Depletion and Noncanonical Scurvy in Mice","volume":"48","author":"Zito","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2025.108037_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107525","article-title":"Role of the ERO1-PDI interaction in oxidative protein folding and disease","volume":"210","author":"Shergalis","year":"2020","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.phrs.2025.108037_bib45","article-title":"A chemical chaperone improves muscle function in mice with a RyR1 mutation","volume":"8","author":"Lee","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.108037_bib46","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrc2394","article-title":"Paul Ehrlich's magic bullet concept: 100 years of progress","volume":"8","author":"Strebhardt","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phrs.2025.108037_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111893","article-title":"Pyrazolone structural motif in medicinal chemistry: Retrospect and prospect","volume":"186","author":"Zhao","year":"2020","journal-title":"Eur. J. Med Chem."},{"key":"10.1016\/j.phrs.2025.108037_bib48","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.bmc.2019.02.016","article-title":"Inhibition of the FAD containing ER oxidoreductin 1 (Ero1) protein by EN-460 as a strategy for treatment of multiple myeloma","volume":"27","author":"Hayes","year":"2019","journal-title":"Bioorg. Med Chem."},{"key":"10.1016\/j.phrs.2025.108037_bib49","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1021\/acsbiomedchemau.1c00062","article-title":"Identification of natural product sulfuretin derivatives as inhibitors for the endoplasmic reticulum redox protein ERO1alpha","volume":"2","author":"Johnson","year":"2022","journal-title":"ACS Bio Med Chem. Au"},{"key":"10.1016\/j.phrs.2025.108037_bib50","doi-asserted-by":"crossref","first-page":"14986","DOI":"10.1021\/acs.jmedchem.4c00535","article-title":"Nonpeptidic irreversible inhibitors of SARS-CoV-2 main protease with potent antiviral activity","volume":"67","author":"Oneto","year":"2024","journal-title":"J. Med Chem."},{"key":"10.1016\/j.phrs.2025.108037_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf7444","article-title":"Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy","volume":"10","author":"Stafford","year":"2018","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.phrs.2025.108037_bib52","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1158\/2159-8290.CD-15-1105","article-title":"Selective Inhibition of Oncogenic KRAS output with small molecules targeting the inactive state","volume":"6","author":"Patricelli","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.phrs.2025.108037_bib53","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.cell.2018.01.006","article-title":"Targeting KRAS mutant cancers with a covalent G12C-specific inhibitor","volume":"172","author":"Janes","year":"2018","journal-title":"Cell"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825004621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825004621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:03:37Z","timestamp":1773810217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825004621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":53,"alternative-id":["S1043661825004621"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.108037","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyrazolone-based ERO1 inhibitors in ERO1-driven triple-negative breast cancer and SEPN1-related myopathy: Structure\u2013activity relationship and therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.108037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108037"}}